Mingyi Li

2.2k citations

97 papers · 1.7k indexed · h-index 27

Impact in

Complementary and alternative medicine top 1%
- Medicinal plant effects and applications
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research

Papers in ⓘ

Molecular Biology 35
- Biological Activity of Diterpenoids and Biflavonoids 8
Oncology 21

Co-authors: Runzhi Zhu (14 shared papers)Jie Liu (8 shared papers)Nianping Chen (10 shared papers)Qingyu Zhang (7 shared papers)Haili Huang (6 shared papers)Huilai Miao (11 shared papers)Min Hu (4 shared papers)Juan Xia (4 shared papers)
Journals: Oncology Reports (4 papers)Frontiers in Oncology (4 papers)PLoS ONE (4 papers)Scientific Reports (2 papers)BMC Surgery (2 papers)
Partner nations: China United States Canada

In The Last Decade

Mingyi Li

90 papers receiving 1.7k citations

Peers

Countries citing papers authored by Mingyi Li

Since Specialization

Citations

This map shows the geographic impact of Mingyi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyi Li more than expected).

Fields of papers citing papers by Mingyi Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyi Li. The network helps show where Mingyi Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Mingyi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mingyi Li Line = papers co-authored together Mingyi Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma Communications Biology ·Purna Mukherjee, Zachary M. Augur, Mingyi Li, Collin Hill, Bennett Greenwood, Marek Domin, Gramoz Kondakci, Niven R. Narain, Michael A. Kiebish, Roderick T. Bronson, Gabriel Arismendi-Morillo, Christos Chinopoulos, Thomas N. Seyfried	2019	101
2	Performance of a Foot-and-Mouth Disease virus Reverse Transcription-Polymerase Chain Reaction with Amplification Controls between Three Real-Time Instruments Journal of Veterinary Diagnostic Investigation ·Mariko Moniwa, Alfonso Clavijo, Mingyi Li, Brad Collignon, R. Kitching	2007	76
3	Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S-phase cell cycle arrest and apoptosis through caspase/cyclin-CDK pathways Molecular Medicine Reports ·Bin Liu, Zhongyou Zhou, Wei Zhou, Jie Liu, Qingyu Zhang, Juan Xia, Juntao Liu, Nianping Chen, Mingyi Li, Runzhi Zhu	2014	72
4	Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism Scientific Reports ·Qingyu Zhang, Jie Liu, Bin Liu, Juan Xia, Nianping Chen, Xiaofeng Chen, Yi Cao, Chen Zhang, Caijie Lu, Mingyi Li, Runzhi Zhu	2014	67
5	Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells PLoS ONE ·Shixing Wu, Bin Liu, Qingyu Zhang, Jie Liu, Wei Zhou, Chang Wang, Mingyi Li, Shiting Bao, Runzhi Zhu	2013	64
6	Chrysin induces cell apoptosis via activation of the p53/Bcl-2/caspase-9 pathway in hepatocellular carcinoma cells Experimental and Therapeutic Medicine ·Qingyu Zhang, Sheng Ma, Bin Liu, Jie Liu, Runzhi Zhu, Mingyi Li	2016	60
7	Experimental inoculation study indicates swine as a potential host for Hendra virus Veterinary Research ·Mingyi Li, Carissa Embury‐Hyatt, Hana M. Weingartl	2010	57
8	Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA Acta Biomaterialia ·Ye Yuan, Jia Liu, Xiangnan Yu, Xingxin Liu, Yanni Cheng, Cheng Zhou, Mingyi Li, Lin Shi, Yan Deng, Huan Liu, Guobin Wang, Lin Wang, Zheng Wang	2021	52
9	Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways Food and Chemical Toxicology ·Juan Xia, Shiwei Guo, Tao Fang, Du Feng, Xingli Zhang, Qingyu Zhang, Jie Liu, Bin Liu, Mingyi Li, Runzhi Zhu	2014	49
10	Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway Oncology Reports ·Haili Huang, Min Hu, Rui Zhao, Peng Li, Mingyi Li	2013	46
11	Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma Oncotarget ·Qingyu Zhang, Caijie Lu, Tao Fang, Yongcun Wang, Wenhua Hu, Jie Qiao, Bin Liu, Jie Liu, Nianping Chen, Mingyi Li, Runzhi Zhu	2015	44
12	AZD8055 induces cell death associated with autophagy and activation of AMPK in hepatocellular carcinoma Oncology Reports ·Min Hu, Haili Huang, Rui Zhao, Peng Li, Mingyi Li, Huilai Miao, Nianping Chen, Ming Chen	2013	42
13	Combination of citrus polymethoxyflavones, green tea polyphenols, and Lychee extracts suppresses obesity and hepatic steatosis in high‐fat diet induced obese mice Molecular Nutrition & Food Research ·Min‐Hsiung Pan, Guliang Yang, Shiming Li, Mingyi Li, Mei‐Ling Tsai, Jia‐Ching Wu, Vladimir Badmaev, Chi‐Tang Ho, Ching‐Shu Lai	2017	42
14	Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells PLoS ONE ·Lianggui Jiang, Qingyu Zhang, Hao Ren, Sheng Ma, Caijie Lu, Bin Liu, Jie Liu, Jian Liang, Mingyi Li, Runzhi Zhu	2015	40
15	ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosis Journal of Hepatology ·Junfeng An, Felix Mehrhof, Christoph Harms, Gisela Lättig-Tünnemann, Sabrina L.L. Lee, Matthias Endres, Mingyi Li, Gernot Sellge, Ana D. Mandić, Christian Trautwein, Stefan Donath	2012	38
16	Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells Oncology Letters ·Jie Liu, Yang Shu, Qingyu Zhang, Bin Liu, Juan Xia, Mingning Qiu, Huilai Miao, Mingyi Li, Runzhi Zhu	2014	38
17	Activation of autophagy inhibits nucleotide‐binding oligomerization domain‐like receptor protein 3 inflammasome activation and attenuates myocardial ischemia‐reperfusion injury in diabetic rats Journal of Diabetes Investigation ·Dengwen Zhang, Yi He, Xiaodong Ye, Yin Cai, Jindong Xu, Liangqing Zhang, Mingyi Li, Hao Liu, Sheng Wang, Zhengyuan Xia	2020	36
18	Claudin-4 controls the proliferation, apoptosis, migration and in vivo growth of MCF-7 breast cancer cells Oncology Reports ·Xiaotang Ma, Huilai Miao, Baoguo Jing, Qunwen Pan, Huiting Zhang, Yanfang Chen, Dan Zhang, Zhongzeng Liang, Zhili Wen, Mingyi Li	2015	35
19	Ion Channel Basis for Alternans and Memory in Cardiac Myocytes Annals of Biomedical Engineering ·Mingyi Li, Niels F. Otani	2003	33
20	Oroxylin A Accelerates Liver Regeneration in CCI4-Induced Acute Liver Injury Mice PLoS ONE ·Runzhi Zhu, Guofang Zeng, Yinqin Chen, Qingyu Zhang, Bin Liu, Jie Liu, Hege Chen, Mingyi Li	2013	33

About Mingyi Li

Mingyi Li is a scholar working on Molecular Biology, Oncology, Epidemiology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 97 papers that have together received 1.7k indexed citations. Recurring topics across this work include Medicinal plant effects and applications (10 papers), Biological Activity of Diterpenoids and Biflavonoids (8 papers), Antenna Design and Analysis (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Microwave Engineering and Waveguides (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Animal Virus Infections Studies (5 papers) and Liver physiology and pathology (5 papers). The work is most often cited by research in Complementary and alternative medicine (270 citations), Cancer Research (335 citations), Molecular Biology (919 citations), Geriatrics and Gerontology (51 citations) and Hepatology (77 citations). Mingyi Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Runzhi Zhu, Jie Liu, Nianping Chen, Qingyu Zhang, Haili Huang, Huilai Miao, Min Hu, Juan Xia, Qingyu Zhang and Niels F. Otani. Their work appears in journals such as Oncology Reports, Frontiers in Oncology, PLoS ONE, Scientific Reports and BMC Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact